CONCHO RESOURCES INC. 8.625% Senior Notes due 2017 Underwriting Agreement
Exhibit
1.1
Execution Version
$300,000,000
8.625% Senior Notes due 2017
September 15, 2009
X.X. Xxxxxx Securities Inc.
As Representative of the
several Underwriters listed
in Schedule 1 hereto
c/o X.X. Xxxxxx Securities Inc.
000 Xxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
As Representative of the
several Underwriters listed
in Schedule 1 hereto
c/o X.X. Xxxxxx Securities Inc.
000 Xxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
Ladies and Gentlemen:
Concho Resources Inc., a Delaware corporation (the “Company”), proposes to issue and sell to
the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting
as representative (the “Representative”), $300,000,000 principal amount of its 8.625% Senior Notes
due 2017 (the “Securities”). The Securities will be issued pursuant to an Indenture to be dated as
of September 18, 2009 (the “Base Indenture”), as amended and supplemented by the First Supplemental
Indenture (herein so called) of even date therewith (the Base Indenture, as so amended and
supplemented, being called the “Indenture”) among the Company, the guarantors listed in Schedule 2
hereto (the “Guarantors”) and Xxxxx Fargo Bank, National Association, as trustee (the “Trustee”),
and will be guaranteed on an unsecured senior basis by each of the Guarantors (the “Guarantees”).
The Company hereby confirms its agreement with the several Underwriters concerning the
purchase and sale of the Securities, as follows:
1. Registration Statement. The Company has prepared and filed with the Securities and
Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended, and the rules
and regulations of the Commission thereunder (collectively, the “Securities Act”), a registration
statement on Form S-3 (File No. 333-161809), including a prospectus, relating to the Securities.
Such registration statement, including the information, if any, deemed pursuant to Rule 430A, 430B
or 430C under the Securities Act to be part of the registration statement at the time of its
effectiveness (“Rule 430 Information”), is referred to herein as the “Registration Statement”; and
as used herein, the term “Preliminary Prospectus” means the base prospectus included in such
registration statement (and any amendments thereto), the prospectus supplement filed with the
Commission pursuant to Rule 424(b)(3) under the Securities Act on September 9, 2009 and the
prospectus included in the Registration Statement at the time of its effectiveness that omits Rule
430 Information, and the term “Prospectus” means the prospectus in the form first used (or made
available upon request of purchasers pursuant to Rule 173 under the Securities Act) in connection
with confirmation of sales of the Securities. Any reference in this
Agreement to the Registration Statement, any Preliminary Prospectus or the Prospectus shall be
deemed to refer to and include the documents incorporated by reference therein pursuant to Item 12
of Form S-3 under the Securities Act, as of the effective date of the Registration Statement or the
date of such Preliminary Prospectus or the Prospectus, as the case may be and any reference to
“amend”, “amendment” or “supplement” with respect to the Registration Statement, any Preliminary
Prospectus or the Prospectus shall be deemed to refer to and include any documents filed after such
date under the Securities Exchange Act of 1934, as amended, and the rules and regulations of the
Commission thereunder (collectively, the “Exchange Act”) that are deemed to be incorporated by
reference therein. Capitalized terms used but not defined herein shall have the meanings given to
such terms in the Registration Statement and the Prospectus.
At or prior to the time when sales of the Securities were first made (the “Time of Sale”), the
Company had prepared the following information (collectively, the “Time of Sale Information”): a
Preliminary Prospectus dated September 9, 2009, and each “free-writing prospectus” (as defined
pursuant to Rule 405 under the Securities Act) listed on Annex B hereto.
2. Purchase of the Securities by the Underwriters. (a) The Company agrees to issue
and sell the Securities to the several Underwriters as provided in this Agreement, and each
Underwriter, on the basis of the representations, warranties and agreements set forth herein and
subject to the conditions set forth herein, agrees, severally and not jointly, to purchase from the
Company the respective principal amount of Securities set forth opposite such Underwriter’s name in
Schedule 1 hereto at a price equal to 96.078% of the principal amount thereof plus accrued
interest, if any, from September 18, 2009 to the Closing Date (as defined below). Xxxxxxx Xxxxx &
Associates, Inc., acting as a “qualified independent underwriter” within the meaning of NASD Rule
2720 of the Financial Industry Regulatory Authority, Inc. (“FINRA”) has participated in the
preparation of the Registration Statement and the Prospectus and has exercised the usual standards
of due diligence with respect thereto. The Company will not be obligated to deliver any of the
Securities except upon payment for all the Securities to be purchased as provided herein.
(b) The Company understands that the Underwriters intend to make a public offering of the
Securities as soon after the effectiveness of this Agreement as in the judgment of the
Representative is advisable, and initially to offer the Securities on the terms set forth in the
Prospectus. The Company acknowledges and agrees that the Underwriters may offer and sell
Securities to or through any affiliate of an Underwriter and that any such affiliate may offer and
sell Securities purchased by it to or through any Underwriter.
(c) Payment for and delivery of the Securities will be made at the offices of Xxxxxx & Xxxxxx
LLP, 0000 Xxxxxx Xxxxxx, Xxxxxxx, Xxxxx 00000 at 10:00 A.M., New York City time, on September 18,
2009, or at such other time or place on the same or such other date, not later than the fifth
business day thereafter, as the Representative and the Company may agree upon in writing. The time
and date of such payment and delivery is referred to herein as the “Closing Date”.
(d) Payment for the Securities shall be made by wire transfer in immediately available funds
to the account(s) specified by the Company to the Representative against delivery to the Trustee,
as custodian for The Depository Trust Company, for the account of the
2
Underwriters, of one or more global notes representing the Securities (collectively, the
“Global Note”), with any transfer taxes payable in connection with the sale of the Securities duly
paid by the Company. The Global Note will be made available for inspection by the Representative
not later than 1:00 P.M., New York City time, on the business day prior to the Closing Date.
(e) The Company and the Guarantors acknowledge and agree that the Underwriters are acting
solely in the capacity of an arm’s length contractual counterparty to the Company and the
Guarantors with respect to the offering of Securities contemplated hereby (including in connection
with determining the terms of the offering) and not as a financial advisor or a fiduciary to, or an
agent of, the Company, the Guarantors or any other person. Additionally, neither the
Representative nor any other Underwriter is advising the Company, the Guarantors or any other
person as to any legal, tax, investment, accounting or regulatory matters in any jurisdiction. The
Company and the Guarantors shall consult with their own advisors concerning such matters and shall
be responsible for making their own independent investigation and appraisal of the transactions
contemplated hereby, and the Underwriters shall have no responsibility or liability to the Company
or the Guarantors with respect thereto. Any review by the Underwriters of the Company, the
Guarantors, the transactions contemplated hereby or other matters relating to such transactions
will be performed solely for the benefit of the Underwriters and shall not be on behalf of the
Company or the Guarantors.
3. Representations and Warranties of the Company and the Guarantors. The Company and
the Guarantors jointly and severally represent and warrant to each Underwriter that:
(a) Preliminary Prospectus. No order preventing or suspending the use of any
Preliminary Prospectus has been issued by the Commission, and each Preliminary Prospectus,
at the time of filing thereof, complied in all material respects with the Securities Act and
did not contain any untrue statement of a material fact or omit to state a material fact
required to be stated therein or necessary in order to make the statements therein, in the
light of the circumstances under which they were made, not misleading; provided that
the Company makes no representation and warranty with respect to any statements or omissions
made in reliance upon and in conformity with information relating to any Underwriter
furnished to the Company in writing by such Underwriter through the Representative expressly
for use in any Preliminary Prospectus.
(b) Time of Sale Information. The Time of Sale Information, at the Time of Sale did
not, and at the Closing Date will not, contain any untrue statement of a material fact or
omit to state a material fact necessary in order to make the statements therein, in the
light of the circumstances under which they were made, not misleading; provided that
the Company makes no representation and warranty with respect to any statements or omissions
made in reliance upon and in conformity with information relating to any Underwriter
furnished to the Company in writing by such Underwriter through the Representative expressly
for use in such Time of Sale Information.
(c) Issuer Free Writing Prospectus. Other than the Preliminary Prospectus and the
Prospectus, the Company (including its agents and representatives, other than the
Underwriters in their capacity as such) has not prepared, made, used, authorized,
3
approved or referred to and will not prepare, make, use, authorize, approve or refer to
any “written communication” (as defined in Rule 405 under the Securities Act) that
constitutes an offer to sell or solicitation of an offer to buy the Securities (each such
communication by the Company or its agents and representatives (other than a communication
referred to in clauses (i) and (ii) below) an “Issuer Free Writing Prospectus”) other than
(i) any document not constituting a prospectus pursuant to Section 2(a)(10)(a) of the
Securities Act or Rule 134 under the Securities Act, (ii) the documents listed on Annex B
hereto and any other written communications, in each case approved in writing in advance by
the Representative. Each such Issuer Free Writing Prospectus complied in all material
respects with the Securities Act, has been or will be (within the time period specified in
Rule 433) filed in accordance with the Securities Act (to the extent required thereby) and,
when taken together with the Preliminary Prospectus accompanying, or delivered prior to
delivery of, such Issuer Free Writing Prospectus, did not, and at the Closing Date will not,
contain any untrue statement of a material fact or omit to state a material fact necessary
in order to make the statements therein, in the light of the circumstances under which they
were made, not misleading; provided that the Company makes no representation and
warranty with respect to any statements or omissions made in each such Issuer Free Writing
Prospectus in reliance upon and in conformity with information relating to any Underwriter
furnished to the Company in writing by such Underwriter through the Representative expressly
for use in any Issuer Free Writing Prospectus.
(d) Registration Statement and Prospectus. The Registration Statement is an “automatic
shelf registration statement” as defined under Rule 405 of the Securities Act that has been
filed with the Commission not earlier than three years prior to the date hereof; and no
notice of objection of the Commission to the use of such registration statement or any
post-effective amendment thereto pursuant to Rule 401(g)(2) under the Securities Act has
been received by the Company. No order suspending the effectiveness of the Registration
Statement has been issued by the Commission and no proceeding for that purpose or pursuant
to Section 8A of the Securities Act against the Company or related to the offering has been
initiated or, to the knowledge of the Company, threatened by the Commission; as of the
applicable effective date of the Registration Statement and any amendment thereto, the
Registration Statement complied and will comply in all material respects with the Securities
Act and the Trust Indenture Act of 1939, as amended, and the rules and regulations of the
Commission thereunder (collectively, the “Trust Indenture Act”), and did not and will not
contain any untrue statement of a material fact or omit to state a material fact required to
be stated therein or necessary in order to make the statements therein not misleading; and
as of the date of the Prospectus and any amendment or supplement thereto and as of the
Closing Date, the Prospectus will not contain any untrue statement of a material fact or
omit to state a material fact required to be stated therein or necessary in order to make
the statements therein, in the light of the circumstances under which they were made, not
misleading; provided that the Company makes no representation and warranty with respect to
(i) that part of the Registration Statement that constitutes the Statement of Eligibility
and Qualification (Form T-1) of the Trustee under the Trust Indenture Act or (ii) any
statements or omissions made in reliance upon and in conformity with information relating to
any Underwriter furnished to the Company in writing by such Underwriter through the
Representative expressly for
4
use in the Registration Statement and the Prospectus and any amendment or supplement
thereto.
(e) Incorporated Documents. The documents incorporated by reference in the
Registration Statement, the Prospectus and the Time of Sale Information, when they became
effective or were filed with the Commission, as the case may be, conformed in all material
respects to the requirements of the Exchange Act and none of such documents contained any
untrue statement of a material fact or omitted to state a material fact required to be
stated therein or necessary in order to make the statements therein, in the light of the
circumstances under which they were made, not misleading; and any further documents so filed
and incorporated by reference in the Registration Statement, the Prospectus or the Time of
Sale Information, when such documents become effective or are filed with the Commission, as
the case may be, will conform in all material respects to the requirements of the Securities
Act or the Exchange Act, as applicable, and will not contain any untrue statement of a
material fact or omit to state a material fact required to be stated therein or necessary in
order to make the statements therein, in the light of the circumstances under which they
were made, not misleading.
(f) Financial Statements.
(i) | The financial statements and the related notes thereto of the Company and its consolidated subsidiaries included or incorporated by reference in the Registration Statement, the Time of Sale Information and the Prospectus comply in all material respects with the applicable requirements of the Securities Act and the Exchange Act, as applicable, and present fairly in all material respects the financial position of the Company and its subsidiaries as of the dates indicated and the results of their operations and the changes in their cash flows for the periods specified; such financial statements have been prepared in conformity with generally accepted accounting principles applied on a consistent basis throughout the periods covered thereby, and the supporting schedules included or incorporated by reference in the Registration Statement present fairly in all material respects the information required to be stated therein; and the other financial information included or incorporated by reference in the Registration Statement, the Time of Sale Information and the Prospectus has been derived from the accounting records of the Company and its subsidiaries and presents fairly in all material respects the information shown thereby; and the pro forma financial information and the related notes thereto incorporated by reference in the Registration Statement, the Time of Sale Information and the Prospectus have been prepared in all material respects in accordance with the applicable requirements of the Securities Act and the Exchange Act, as applicable, the assumptions used in preparing the pro forma financial information incorporated by reference in the Registration Statement, the Time of Sale Information and the Prospectus provide a reasonable basis for presenting the significant effects directly attributable to the transactions or events described therein, the related pro forma adjustments give appropriate effect to those |
5
assumptions, and the pro forma columns therein reflect the proper
application of those adjustments to the corresponding historical financial
statement amounts.
(ii) | The financial statements and the related notes thereto of the Xxxxx Group Properties incorporated by reference in the Registration Statement, the Time of Sale Information and the Prospectus (and as defined therein) comply in all material respects with the applicable requirements of the Securities Act and the Exchange Act, as applicable, and present fairly in all material respects the financial position of the Xxxxx Group Properties as of the dates indicated and the results of their operations and the changes in their cash flows for the periods specified; such financial statements have been prepared in conformity with generally accepted accounting principles applied on a consistent basis throughout the periods covered thereby, the other financial information of the Xxxxx Group Properties included in the Registration Statement, the Time of Sale Information and the Prospectus has been derived from the accounting records of the Xxxxx Group Properties and presents fairly in all material respects the information shown thereby. | ||
(iii) | The financial information of the Xxxx Properties included in the Registration Statement, the Time of Sale Information and the Prospectus of the Xxxx Properties complies in all material respects with the applicable requirements of the Securities Act and the Exchange Act, as applicable, and presents fairly in all material respects the revenues and direct operating expenses of the Xxxx Properties for the periods specified. | ||
(iv) | The financial information of the Chase Group Properties included in the Registration Statement, the Time of Sale Information and the Prospectus complies in all material respects with the applicable requirements of the Securities Act and the Exchange Act, as applicable, and presents fairly in all material respects the financial position of the Chase Group Properties as of the dates indicated and the results of their operations and the changes in their cash flows for the periods specified and presents fairly in all material respects the information shown thereby. |
(g) No Material Adverse Change. Since the date of the most recent financial statements
of the Company included or incorporated by reference in the Registration Statement, the Time
of Sale Information and the Prospectus, (i) there has not been any change in the capital
stock or material change in the long-term debt of the Company or any of its subsidiaries, or
any dividend or distribution of any kind declared, set aside for payment, paid or made by
the Company on any class of capital stock, or any material adverse change, or any
development involving a prospective material adverse change, in or affecting the business,
properties, management, financial position, results of operations or prospects of the
Company and its subsidiaries taken as a whole; (ii) neither the Company nor any of its
subsidiaries has entered into any transaction or agreement that is material to the Company
and its subsidiaries taken as a whole or incurred any liability or
6
obligation, direct or contingent, that is material to the Company and its subsidiaries
taken as a whole; and (iii) neither the Company nor any of its subsidiaries has sustained
any material loss or interference with its business from fire, explosion, flood or other
calamity, whether or not covered by insurance, or from any labor disturbance or dispute or
any action, order or decree of any court or arbitrator or governmental or regulatory
authority, except in each case as otherwise disclosed in the Registration Statement, the
Time of Sale Information and the Prospectus.
(h) Organization and Good Standing. The Company and each of its subsidiaries have been
duly organized and are validly existing and in good standing under the laws of their
respective jurisdictions of organization, are duly qualified to do business and are in good
standing in each jurisdiction in which their respective ownership or lease of property or
the conduct of their respective businesses requires such qualification, and have all power
and authority necessary to own or hold their respective properties and to conduct the
businesses in which they are engaged, except where the failure to be so qualified, in good
standing or have such power or authority would not, individually or in the aggregate, have a
material adverse effect on the business, properties, management, financial position, results
of operations or prospects of the Company and its subsidiaries taken as a whole or on the
performance by the Company or the Guarantors of their obligations under the Securities and
the Guarantees, respectively (a “Material Adverse Effect”). The Company does not own or
control, directly or indirectly, any corporation, association or other entity other than the
Guarantors.
(i) Capitalization. The Company has an authorized capitalization as set forth in the
Registration Statement, the Time of Sale Information and the Prospectus under the heading
“Capitalization” and all the outstanding shares of capital stock or other equity interests
of each subsidiary of the Company have been duly and validly authorized and issued, are
fully paid and non-assessable (except as otherwise described in the Registration Statement,
the Time of Sale Information and the Prospectus) and are owned directly or indirectly by the
Company, free and clear of any lien, charge, encumbrance, security interest, restriction on
voting or transfer or any other claim of any third party, other than those arising under the
Company’s Amended and Restated Credit Agreement, dated as of July 31, 2008.
(j) Due Authorization. The Company and each of the Guarantors have full corporate or
limited liability company power and authority to execute and deliver this Agreement, the
Securities and the Base Indenture and the First Supplemental Indenture (collectively, the
“Transaction Documents”) and to perform their respective obligations hereunder and
thereunder; and all corporate or limited liability company action required to be taken for
the due and proper authorization, execution and delivery of each of the Transaction
Documents to which each of them are a party and the consummation by each of them of the
transactions contemplated thereby has been duly and validly taken.
(k) The Indenture. Each of the Base Indenture and the Supplemental Indenture has been
duly authorized by the Company and each of the Guarantors and upon effectiveness of the
Registration Statement the Indenture was or will have been duly qualified under the Trust
Indenture Act and, when each of the Base Indenture and the
7
First Supplemental Indenture have been duly executed and delivered in accordance with
its terms by each of the parties thereto, the Indenture will constitute a valid and legally
binding agreement of the Company and each of the Guarantors enforceable against the Company
and each of the Guarantors in accordance with its terms, except as enforceability may be
limited by applicable bankruptcy, insolvency, moratorium, fraudulent transfer or similar
laws affecting the enforcement of creditors’ rights generally or by equitable principles
(whether considered in a proceeding at law or in equity) relating to enforceability
(collectively, the “Enforceability Exceptions”).
(l) The Securities and the Guarantees. The Securities have been duly authorized by the
Company and, when duly executed, authenticated, issued and delivered as provided in the
Indenture and paid for as provided herein, will be duly and validly issued and outstanding
and will constitute valid and legally binding obligations of the Company enforceable against
the Company in accordance with their terms, subject to the Enforceability Exceptions, and
will be entitled to the benefits of the Indenture; and the Guarantees have been duly
authorized by each of the Guarantors and, when the Securities have been duly executed,
authenticated, issued and delivered as provided in the Indenture and paid for as provided
herein, will be valid and legally binding obligations of each of the Guarantors, enforceable
against each of the Guarantors in accordance with their terms, subject to the Enforceability
Exceptions, and will be entitled to the benefits of the Indenture.
(m) Underwriting Agreement. This Agreement has been duly authorized, executed and
delivered by the Company and the Guarantors.
(n) Descriptions of the Transaction Documents. Each Transaction Document conforms in
all material respects to the description thereof contained in the Registration Statement,
the Time of Sale Information and the Prospectus.
(o) No Violation or Default. Neither the Company nor any of its subsidiaries is (i) in
violation of its charter or by-laws or similar organizational documents; (ii) in default,
and no event has occurred that, with notice or lapse of time or both, would constitute such
a default, in the due performance or observance of any term, covenant or condition contained
in any indenture, mortgage, deed of trust, loan agreement or other agreement or instrument
to which the Company or any of its subsidiaries is a party or by which the Company or any of
its subsidiaries is bound or to which any of the property or assets of the Company or any of
its subsidiaries is subject; or (iii) in violation of any law or statute or any judgment,
order, rule or regulation of any court or arbitrator or governmental or regulatory
authority, except, in the case of clauses (ii) and (iii) above, for any such default or
violation that would not, individually or in the aggregate, have a Material Adverse Effect.
(p) No Conflicts. The execution, delivery and performance by the Company and each of
the Guarantors of each of the Transaction Documents to which each is a party, the issuance
and sale of the Securities (including the Guarantees) and compliance by the Company and each
of the Guarantors with the terms thereof and the consummation of the transactions
contemplated by the Transaction Documents will not (i) conflict with
8
or result in a breach or violation of any of the terms or provisions of, or constitute
a default under, or result in the creation or imposition of any lien, charge or encumbrance
upon any property or assets of the Company or any of its subsidiaries pursuant to, any
indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which
the Company or any of its subsidiaries is a party or by which the Company or any of its
subsidiaries is bound or to which any of the property or assets of the Company or any of its
subsidiaries is subject, (ii) result in any violation of the provisions of the charter or
by-laws or similar organizational documents of the Company or any of its subsidiaries or
(iii) result in the violation of any law or statute or any judgment, order, rule or
regulation of any court or arbitrator or governmental or regulatory authority, except, in
the case of clauses (i) and (iii) above, for any such conflict, breach, violation, default,
lien, charge or encumbrance that would not, individually or in the aggregate, have a
Material Adverse Effect.
(q) No Consents Required. No consent, approval, authorization, order, registration or
qualification of or with any court or arbitrator or governmental or regulatory authority is
required for the execution, delivery and performance by the Company and each of the
Guarantors of each of the Transaction Documents to which each is a party, the issuance and
sale of the Securities (including the Guarantees) and compliance by the Company and each of
the Guarantors with the terms thereof and the consummation of the transactions contemplated
by the Transaction Documents, except for the registration of the Securities under the
Securities Act, the qualification of the Indenture under the Trust Indenture Act and such
consents, approvals, authorizations, orders and registrations or qualifications as may be
required under applicable state securities laws in connection with the purchase and
distribution of the Securities by the Underwriters and any consent, approval, authorization,
order, registration or qualification that either has been, or prior to the Closing Date will
have been, obtained or made, or which if not obtained or made, would not, individually or in
the aggregate, have a Material Adverse Effect and would not adversely affect the Company’s
and the Guarantors’ ability to fulfill their respective obligations under this Agreement.
(r) Legal Proceedings. Except as described in the Registration Statement, the Time of
Sale Information and the Prospectus, there are no legal, governmental or regulatory
investigations, actions, suits or proceedings pending to which the Company or any of its
subsidiaries is or may be a party or to which any property of the Company or any of its
subsidiaries is or may be the subject that, individually or in the aggregate, if determined
adversely to the Company or any of its subsidiaries, could reasonably be expected to have a
Material Adverse Effect or materially and adversely affect the ability of the Company to
perform its obligations under this Agreement; to the knowledge of the Company and each of
its subsidiaries, no such investigations, actions, suits or proceedings are threatened or
contemplated by any governmental or regulatory authority or others; and (i) there are no
current or pending legal, governmental or regulatory actions, suits or proceedings that are
required under the Securities Act to be described in the Registration Statement or the
Prospectus that are not so described in the Registration Statement, the Time of Sale
Information and the Prospectus and (ii) there are no statutes, regulations or contracts or
other documents that are required under the Securities Act to be filed as exhibits to the
Registration Statement or described in the Registration
9
Statement or the Prospectus that are not so filed as exhibits to the Registration
Statement or described in the Registration Statement, the Time of Sale Information and the
Prospectus.
(s) Independent Accountants. Xxxxx Xxxxxxxx LLP, who have certified certain financial
statements of the Company and its subsidiaries, is an independent registered public
accounting firm with respect to the Company and its subsidiaries within the applicable rules
and regulations adopted by the Commission and the Public Company Accounting Oversight Board
(United States) and as required by the Securities Act. Xxxxx Xxxxxx & Co., P.C., who have
certified certain financial statements of the Xxxxx Group Properties are independent
certified public accountants with respect to the Company and its subsidiaries within the
applicable rules and regulations adopted by the Commission and the Public Company Accounting
Oversight Board (United States) and as required by the Securities Act.
(t) Title to Real and Personal Property. The Company and its subsidiaries have good
and marketable title to all real and other property they own, in each case free and clear of
all liens, encumbrances and defects except those (i) described in the Registration
Statement, the Time of Sale Information and the Prospectus or (ii) that could not reasonably
be expected, individually or in the aggregate, to have a Material Adverse Effect. Except as
described in the Registration Statement, the Time of Sale Information and the Prospectus,
all items of real and other property leased by the Company and its subsidiaries are leased
under valid and enforceable leases, except as could not reasonably be expected, individually
or in the aggregate, to have a Material Adverse Effect.
(u) Title to Intellectual Property. The Company and its subsidiaries own or possess
adequate rights to use all material patents, patent applications, trademarks, service marks,
trade names, trademark registrations, service xxxx registrations, copyrights, licenses and
know-how (including trade secrets and other unpatented and/or unpatentable proprietary or
confidential information, systems or procedures) necessary for the conduct of their
respective businesses; and the Company and its subsidiaries have not received any notice of
any claim of infringement of or conflict with any such rights of others.
(v) No Undisclosed Relationships. No relationship, direct or indirect, exists between
or among the Company or any of its subsidiaries, on the one hand, and the directors,
officers, stockholders, customers or suppliers of the Company or any of its subsidiaries, on
the other, that is required by the Securities Act to be described in the Registration
Statement and the Prospectus and that is not so described in such documents and in the Time
of Sale Information.
(w) Investment Company Act. Neither the Company nor any of its subsidiaries is and,
after giving effect to the offering and sale of the Securities and the application of the
proceeds thereof as described in the Registration Statement, the Time of Sale Information
and the Prospectus, none of them will be, an “investment company” or an entity “controlled”
by an “investment company” within the meaning of the Investment
10
Company Act of 1940, as amended, and the rules and regulations of the Commission
thereunder (collectively, “Investment Company Act”).
(x) Taxes. The Company and its subsidiaries have paid all federal, state, local and
foreign taxes and filed all tax returns required to be paid or filed through the date
hereof; and except as otherwise disclosed in the Registration Statement, the Time of Sale
Information and the Prospectus or as would not, individually or in the aggregate, have a
Material Adverse Effect, there is no tax deficiency that has been, or could reasonably be
expected to be, asserted against the Company or any of its subsidiaries or any of their
respective properties or assets.
(y) Licenses and Permits. The Company and its subsidiaries possess all licenses,
certificates, permits and other authorizations issued by, and have made all declarations and
filings with, the appropriate federal, state, local or foreign governmental or regulatory
authorities that are necessary for the ownership or lease of their respective properties or
the conduct of their respective businesses as described in the Registration Statement, the
Time of Sale Information and the Prospectus, except where the failure to possess or make the
same would not, individually or in the aggregate, have a Material Adverse Effect; and except
as described in the Registration Statement, the Time of Sale Information and the Prospectus
or as would not, individually or in the aggregate, have a Material Adverse Effect, neither
the Company nor any of its subsidiaries has received notice of any revocation or
modification of any such license, certificate, permit or authorization or has any reason to
believe that any such license, certificate, permit or authorization will not be renewed in
the ordinary course.
(z) No Labor Disputes. No labor disturbance by or dispute with employees of the
Company or any of its subsidiaries exists or, to the knowledge of the Company and each of
the Guarantors, is contemplated or threatened and neither the Company nor any Guarantor is
aware of any existing or imminent labor disturbance by, or dispute with, the employees of
any of the Company’s or the Company’s subsidiaries’ principal suppliers, contractors or
customers, except as would not have a Material Adverse Effect.
(aa) Compliance With Environmental Laws. (i) The Company and its subsidiaries (x) are
in compliance with any and all applicable federal, state, local and foreign laws, rules,
regulations, requirements, decisions and orders relating to the protection of human health
and safety, the environment, hazardous or toxic substances or wastes, pollutants or
contaminants (collectively, “Environmental Laws”); (y) have received and are in compliance
with all permits, licenses, certificates or other authorizations or approvals required of
them under applicable Environmental Laws to conduct their respective businesses; and (z)
except as described in the Registration Statement, the Time of Sale Information and the
Prospectus, have not received notice of any actual or potential liability for the
investigation or remediation of any disposal or release of hazardous or toxic substances or
wastes, pollutants or contaminants, and (ii) there are no costs or liabilities associated
with Environmental Laws of or relating to the Company or its subsidiaries, except in the
case of each of (i) and (ii) above, for any such failure to comply, or failure to receive
required permits, licenses or approvals, or cost or liability, as would not, individually or
in the aggregate, have a Material Adverse Effect.
11
(bb) Compliance With ERISA. Each employee benefit plan, within the meaning of Section
3(3) of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”), that is
maintained, administered or contributed to by the Company or any of its affiliates for
employees or former employees of the Company and its affiliates has been maintained in
compliance in all material respects with its terms and the requirements of any applicable
statutes, orders, rules and regulations, including, but not limited to, ERISA and the
Internal Revenue Code of 1986, as amended (the “Code”); no prohibited transaction, within
the meaning of Section 406 of ERISA or Section 4975 of the Code, has occurred with respect
to any such plan excluding transactions effected pursuant to a statutory or administrative
exemption; and transactions which, individually or in the aggregate, would not have a
Material Adverse Effect, and no such plan is subject to the funding rules of Section 412 of
the Code or Section 302 of ERISA.
(cc) Disclosure Controls. The Company and its subsidiaries maintain an effective
system of “disclosure controls and procedures” (as defined in Rule 13a-15(e) of the Exchange
Act) that is designed to ensure that information required to be disclosed by the Company in
reports that it files or submits under the Exchange Act is recorded, processed, summarized
and reported within the time periods specified in the Commission’s rules and forms,
including controls and procedures designed to provide reasonable assurance that such
information is accumulated and communicated to the Company’s management as appropriate to
allow timely decisions regarding required disclosure.
(dd) Accounting Controls. The Company and its subsidiaries maintain a system of
“internal control over financial reporting” (as defined in Rule 13a-15(f) of the Exchange
Act) that comply with the requirements of the Exchange Act and have been designed by, or
under the supervision of, the Company’s principal executive and principal financial
officers, and effected by the Company’s board of directors, management and other personnel
to provide reasonable assurance regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in accordance with generally
accepted accounting principles, including those policies and procedures that (i) pertain to
the maintenance of records that in reasonable detail accurately and fairly reflect the
transactions and dispositions of the assets of the Company; (ii) provide reasonable
assurance that transactions are recorded as necessary to permit preparation of financial
statements in accordance with generally accepted accounting principles and that receipts and
expenditures of the Company are being made in accordance with and authorizations of
management and directors of the Company; and (iii) provide reasonable assurance regarding
prevention or timely detection of unauthorized acquisition, use or disposition of the
Company’s assets that could have a material effect on the Company’s financial statements.
Except as disclosed in the Registration Statement, the Time of Sale Information and the
Prospectus, there are no material weaknesses in the Company’s internal control over
financial reporting.
(ee) Insurance. The Company and its subsidiaries have insurance covering their
respective properties, operations, personnel and businesses, which insurance is in
reasonable amounts and insures against such losses and risks as are reasonably adequate to
protect the Company and its subsidiaries and their respective businesses; and neither
12
the Company nor any of its subsidiaries has (i) received notice from any insurer or
agent of such insurer that capital improvements or other expenditures are required or
necessary to be made in order to continue such insurance or (ii) any reason to believe that
it will not be able to renew its existing insurance coverage as and when such coverage
expires or to obtain similar coverage at reasonable cost from similar insurers as may be
necessary to continue its business.
(ff) No Unlawful Payments. Neither the Company nor any of its subsidiaries nor, to the
knowledge of the Company and each of the Guarantors, any director, officer, agent, employee
or other person associated with or acting on behalf of the Company or any of its
subsidiaries has (i) used any corporate funds for any unlawful contribution, gift,
entertainment or other unlawful expense relating to political activity; (ii) made any direct
or indirect unlawful payment to any foreign or domestic government official or employee from
corporate funds; (iii) violated or is in violation of any provision of the Foreign Corrupt
Practices Act of 1977; or (iv) made any bribe, rebate, payoff, influence payment, kickback
or other unlawful payment.
(gg) Compliance with Money Laundering Laws. The operations of the Company and its
subsidiaries are and have been conducted at all times in compliance with applicable
financial recordkeeping and reporting requirements of the Currency and Foreign Transactions
Reporting Act of 1970, as amended, the money laundering statutes of all jurisdictions, the
rules and regulations thereunder and any related or similar rules, regulations or
guidelines, issued, administered or enforced by any governmental agency (collectively, the
“Money Laundering Laws”) and no action, suit or proceeding by or before any court or
governmental agency, authority or body or any arbitrator involving the Company or any of its
subsidiaries with respect to the Money Laundering Laws is pending or, to the knowledge of
the Company, threatened.
(hh) Compliance with OFAC. None of the Company, any of its subsidiaries or, to the
knowledge of the Company, any director, officer, agent, employee or Affiliate of the Company
or any of its subsidiaries is currently subject to any U.S. sanctions administered by the
Office of Foreign Assets Control of the U.S. Department of the Treasury (“OFAC”); and the
Company will not directly or indirectly use the proceeds of the offering of the Securities
hereunder, or lend, contribute or otherwise make available such proceeds to any subsidiary,
joint venture partner or other person or entity, for the purpose of financing the activities
of any person currently subject to any U.S. sanctions administered by OFAC.
(ii) No Restrictions on Subsidiaries. No subsidiary of the Company is currently
prohibited, directly or indirectly, under any agreement or other instrument to which it is a
party or is subject, from paying any dividends to the Company, from making any other
distribution on such subsidiary’s capital stock, from repaying to the Company any loans or
advances to such subsidiary from the Company or from transferring any of such subsidiary’s
properties or assets to the Company or any other subsidiary of the Company.
(jj) No Broker’s Fees. Neither the Company nor any of its subsidiaries is a party to
any contract, agreement or understanding with any person (other than this
13
Agreement) that would give rise to a valid claim against the Company or any of its
subsidiaries or any Underwriter for a brokerage commission, finder’s fee or like payment in
connection with the offering and sale of the Securities.
(kk) No Registration Rights. Except as disclosed in the Registration Statement, the
Time of Sale Information and the Prospectus, no person has the right to require the Company
or any of its subsidiaries to register any securities for sale under the Securities Act by
reason of the filing of the Registration Statement with the Commission or the issuance and
sale of the Securities.
(ll) No Stabilization. The Company has not taken, directly or indirectly, any action
designed to or that could reasonably be expected to cause or result in any stabilization or
manipulation of the price of the Securities.
(mm) Forward-Looking Statements. No material forward-looking statement (within the
meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act) contained
in the Registration Statement, the Time of Sale Information and the Prospectus has been made
or reaffirmed without a reasonable basis or has been disclosed other than in good faith.
(nn) Xxxxxxxx-Xxxxx Act. There is and has been no failure on the part of the Company
or any of the Company’s directors or officers, in their capacities as such, to comply with
any applicable provision of the Xxxxxxxx-Xxxxx Act of 2002 and any applicable rules and
regulations promulgated in connection therewith (the “Xxxxxxxx-Xxxxx Act”), including
Section 402 related to loans and Sections 302 and 906 related to certifications.
(oo) Status under the Securities Act. The Company is not an ineligible issuer and is a
well-known seasoned issuer, in each case as defined under the Securities Act, in each case
at the times specified in the Securities Act in connection with the offering of the
Securities.
(pp) Reserve Data. The oil and natural gas reserve estimates of the Company and its
subsidiaries as of December 31, 2006, 2007 and 2008 contained in the Registration Statement,
the Time of Sale Information and the Prospectus are derived from reports that have been
prepared by, or have been audited by, either (a) Netherland, Xxxxxx & Associates, Inc. or
(b) Xxxxxx, Xxxxxxxxx & Associates, Inc., as set forth and to the extent indicated therein,
and such estimates fairly reflect, in all material respects, the oil and natural gas
reserves of the Company and its subsidiaries, as applicable, at the dates indicated therein
and are in accordance, in all material respects, with Commission guidelines applied on a
consistent basis throughout the periods involved.
(qq) Independent Petroleum Engineers. Each of Netherland, Xxxxxx & Associates, Inc.
and Xxxxxx, Xxxxxxxxx & Associates, Inc. have represented to the Company that they are, and
the Company believes them to be, independent petroleum engineers with respect to the Company
and its subsidiaries and for the periods set forth in the Time of Sale Information and the
Prospectus.
14
4. Further Agreements of the Company and the Guarantors. The Company and each of the
Guarantors jointly and severally covenant and agree with each Underwriter that:
(a) Required Filings. The Company will file the final Prospectus with the Commission within
the time periods specified by Rule 424(b) and Rule 430A, 430B or 430C under the Securities Act,
will file any Issuer Free Writing Prospectus to the extent required by Rule 433 under the
Securities Act; and will file promptly all reports and any definitive proxy or information
statements required to be filed by the Company with the Commission pursuant to Section 13(a),
13(c), 14 or 15(d) of the Exchange Act subsequent to the date of the Prospectus and for so long as
the delivery of a prospectus is required in connection with the offering or sale of the Securities;
and the Company will furnish copies of the Prospectus and each Issuer Free Writing Prospectus (to
the extent not previously delivered) to the Underwriters in New York City prior to 10:00 A.M., New
York City time, on the business day next succeeding the date of this Agreement in such quantities
as the Representative may reasonably request.
(b) Delivery of Copies. The Company will make available to each Underwriter electronically
through XXXXX the Registration Statement as originally filed and each amendment thereto, in each
case including all exhibits and consents filed therewith and documents incorporated by reference
therein, and (ii) make available to each Underwriter electronically through XXXXX (A) a conformed
copy of the Registration Statement as originally filed and each amendment thereto filed prior to
the later of (x) the Closing Date or (y) the expiration of the Prospectus Delivery Period (as
defined below) or otherwise relating to the Securities, in each case including all exhibits and
consents filed therewith and (B) deliver, without charge, during the Prospectus Delivery Period (as
defined below), as many copies of the Prospectus (including all amendments and supplements thereto)
and each Issuer Free Writing Prospectus as the Representative may reasonably request. As used
herein, the term “Prospectus Delivery Period” means such period of time after the first date of the
public offering of the Securities as in the opinion of counsel for the Underwriters a prospectus
relating to the Securities is required by law to be delivered (or required to be delivered but for
Rule 172 under the Securities Act) in connection with sales of the Securities by any Underwriter or
dealer.
(c) Amendments or Supplements; Issuer Free Writing Prospectuses. Prior to the later of (i)
the Closing Date or (ii) the expiration of the Prospectus Delivery Period, before preparing, using,
authorizing, approving, referring to or filing any Issuer Free Writing Prospectus, and before
filing any amendment or supplement to the Registration Statement or the Prospectus, the Company
will furnish to the Representative and counsel for the Underwriters a copy of the proposed Issuer
Free Writing Prospectus, amendment or supplement for review and will not prepare, use, authorize,
approve, refer to or file any such Issuer Free Writing Prospectus or file any such proposed
amendment or supplement to which the Representative reasonably objects.
(d) Notice to the Representative. The Company will advise the Representative promptly, and
confirm such advice in writing, (i) when any amendment to the Registration Statement has been filed
or becomes effective prior to the later of (i) the Closing Date or (ii) the expiration of the
Prospectus Delivery Period; (ii) when any supplement to the Prospectus or any amendment to the
Prospectus or any Issuer Free Writing Prospectus relating to the Securities has been filed; (iii)
of any request by the Commission for any amendment to the Registration Statement or any amendment
or supplement to the Prospectus or the receipt of any comments
15
from the Commission relating to the Registration Statement or any other request by the
Commission for any additional information relating to the Registration Statement or any document
incorporated therein as of the later of later of (x) the Closing Date or (y) the expiration of the
Prospectus Delivery Period; (iv) of the issuance by the Commission of any order suspending the
effectiveness of the Registration Statement or preventing or suspending the use of any Preliminary
Prospectus or the Prospectus or the initiation or threatening of any proceeding for that purpose or
pursuant to Section 8A of the Securities Act; (v) of the occurrence of any event within the
Prospectus Delivery Period as a result of which the Prospectus, the Time of Sale Information or any
Issuer Free Writing Prospectus as then amended or supplemented would include any untrue statement
of a material fact or omit to state a material fact required to be stated therein or necessary in
order to make the statements therein, in the light of the circumstances existing when the
Prospectus, the Time of Sale Information or any such Issuer Free Writing Prospectus is delivered to
a purchaser, not misleading; (vi) of the receipt by the Company of any notice of objection of the
Commission to the use of the Registration Statement or any post-effective amendment thereto
pursuant to Rule 401(g)(2) under the Securities Act; and (vii) of the receipt by the Company of any
notice with respect to any suspension of the qualification of the Securities for offer and sale in
any jurisdiction or the initiation or threatening of any proceeding for such purpose; and the
Company will use its reasonable best efforts to prevent the issuance of any such order suspending
the effectiveness of the Registration Statement, preventing or suspending the use of any
Preliminary Prospectus or the Prospectus or suspending any such qualification of the Securities
and, if any such order is issued, will obtain as soon as possible the withdrawal thereof.
(e) Time of Sale Information. If at any time prior to the Closing Date (i) any event shall
occur or condition shall exist as a result of which the Time of Sale Information as then amended or
supplemented would include any untrue statement of a material fact or omit to state any material
fact necessary in order to make the statements therein, in the light of the circumstances, not
misleading or (ii) it is necessary to amend or supplement the Time of Sale Information to comply
with law, the Company will promptly notify the Underwriters thereof and forthwith prepare and,
subject to paragraph (c) above, file with the Commission (to the extent required) and furnish to
the Underwriters and to such dealers as the Representative may designate, such amendments or
supplements to the Time of Sale Information as may be necessary so that the statements in the Time
of Sale Information as so amended or supplemented will not, in the light of the circumstances, be
misleading or so that the Time of Sale Information will comply with law.
(f) Ongoing Compliance. If during the Prospectus Delivery Period (i) any event shall occur or
condition shall exist as a result of which the Prospectus as then amended or supplemented would
include any untrue statement of a material fact or omit to state any material fact required to be
stated therein or necessary in order to make the statements therein, in the light of the
circumstances existing when the Prospectus is delivered to a purchaser, not misleading or (ii) it
is necessary to amend or supplement the Prospectus to comply with law, the Company will promptly
notify the Underwriters thereof and forthwith prepare and, subject to paragraph (c) above, file
with the Commission and furnish to the Underwriters and to such dealers as the Representative may
designate, such amendments or supplements to the Prospectus as may be necessary so that the
statements in the Prospectus as so amended or supplemented will not, in the
16
light of the circumstances existing when the Prospectus is delivered to a purchaser, be
misleading or so that the Prospectus will comply with law.
(g) Blue Sky Compliance. The Company will qualify the Securities for offer and sale under the
securities or Blue Sky laws of such jurisdictions as the Representative shall reasonably request
and will continue such qualifications in effect so long as required for distribution of the
Securities; provided that the Company shall not be required to (i) qualify as a foreign
corporation or other entity or as a dealer in securities in any such jurisdiction where it would
not otherwise be required to so qualify, (ii) file any general consent to service of process in any
such jurisdiction or (iii) subject itself to taxation in any such jurisdiction if it is not
otherwise so subject.
(h) Earning Statement. The Company will make generally available to its security holders and
the Representative as soon as practicable an earning statement that satisfies the provisions of
Section 11(a) of the Securities Act and Rule 158 of the Commission promulgated thereunder covering
a period of at least twelve months beginning with the first fiscal quarter of the Company occurring
after the “effective date” (as defined in Rule 158) of the Registration Statement.
(i) Clear Market. During the period from the date hereof through and including the date that
is 45 days after the date hereof, the Company will not, without the prior written consent of the
Representative, offer, sell, contract to sell or otherwise dispose of any debt securities issued or
guaranteed by the Company and having a tenor of more than one year.
(j) Use of Proceeds. The Company will apply the net proceeds from the sale of the Securities
as described in the Registration Statement, the Time of Sale Information and the Prospectus under
the heading “Use of proceeds”.
(k) No Stabilization. The Company will not take, directly or indirectly, any action designed
to or that could reasonably be expected to cause or result in any stabilization or manipulation of
the price of the Securities.
(l) Record Retention. The Company will, pursuant to reasonable procedures developed in good
faith, retain copies of each Issuer Free Writing Prospectus that is not filed with the Commission
in accordance with Rule 433 under the Securities Act.
5. Certain Agreements of the Underwriters. Each Underwriter hereby represents and
agrees that:
(a) It has not and will not use, authorize use of, refer to, or participate in the planning
for use of, any “free writing prospectus”, as defined in Rule 405 under the Securities Act (which
term includes use of any written information furnished to the Commission by the Company and not
incorporated by reference into the Registration Statement and any press release issued by the
Company) other than (i) a free writing prospectus that, solely as a result of use by such
underwriter, would not trigger an obligation to file such free writing prospectus with the
Commission pursuant to Rule 433, (ii) any Issuer Free Writing Prospectus listed on Annex B or
prepared pursuant to Section 3(c) or Section 4(c) above, or (iii) any free writing prospectus
prepared by such Underwriter and approved by the Company in advance in writing (each such free
writing prospectus referred to in clauses (i) or (iii), an “Underwriter Free Writing
17
Prospectus”). Notwithstanding the foregoing, the Underwriters may use a term sheet
substantially in the form of Annex C hereto without the consent of the Company.
(b) It is not subject to any pending proceeding under Section 8A of the Securities Act with
respect to the offering (and will promptly notify the Company if any such proceeding against it is
initiated during the Prospectus Delivery Period).
6. Conditions of Underwriters’ Obligations. The obligation of each Underwriter to
purchase Securities on the Closing Date as provided herein is subject to the performance by the
Company and each of the Guarantors of their respective covenants and other obligations hereunder
and to the following additional conditions:
(a) Registration Compliance; No Stop Order. No order suspending the effectiveness of the
Registration Statement shall be in effect, and no proceeding for such purpose, pursuant to Rule
401(g)(2) or pursuant to Section 8A under the Securities Act shall be pending before or threatened
by the Commission; the Prospectus and each Issuer Free Writing Prospectus shall have been timely
filed with the Commission under the Securities Act (in the case of an Issuer Free Writing
Prospectus, to the extent required by Rule 433 under the Securities Act) and in accordance with
Section 4(a) hereof; and all requests by the Commission for additional information shall have been
complied with to the reasonable satisfaction of the Representative.
(b) Representations and Warranties. The representations and warranties of the Company and
each of the Guarantors contained herein shall be true and correct on the date hereof and on and as
of the Closing Date; and the statements of the Company and each of the Guarantors and their
respective officers made in any certificates delivered pursuant to this Agreement shall be true and
correct on and as of the Closing Date.
(c) No Downgrade. Subsequent to the earlier of (A) the Time of Sale and (B) the execution and
delivery of this Agreement, (i) no downgrading shall have occurred in the rating accorded the
Securities or any other debt securities or preferred stock of or guaranteed by the Company or any
of its subsidiaries by any “nationally recognized statistical rating organization”, as such term is
defined by the Commission for purposes of Rule 436(g)(2) under the Securities Act and (ii) no such
organization shall have publicly announced that it has under surveillance or review, or has changed
its outlook with respect to, its rating of the Securities or of any other debt securities or
preferred stock of or guaranteed by the Company or any of its subsidiaries (other than an
announcement with positive implications of a possible upgrading).
(d) No Material Adverse Change. No event or condition of a type described in Section 3(g)
hereof shall have occurred or shall exist, which event or condition is not described in the Time of
Sale Information (excluding any amendment or supplement thereto) and the Prospectus (excluding any
amendment or supplement thereto) and the effect of which in the judgment of the Representative
makes it impracticable or inadvisable to proceed with the offering, sale or delivery of the
Securities on the terms and in the manner contemplated by this Agreement, the Time of Sale
Information and the Prospectus.
(e) Officer’s Certificate. The Representative shall have received on and as of the Closing
Date a certificate of an executive officer of the Company and of each Guarantor who has
18
specific knowledge of the Company’s or such Guarantor’s financial matters and is satisfactory
to the Representative (i) confirming that such officer has carefully reviewed the Registration
Statement, the Time of Sale Information and the Prospectus and, to the knowledge of such officer,
the representations set forth in Sections 3(b) or 3(d) hereof are true and correct, (ii) confirming
that the other representations and warranties of the Company and the Guarantors in this Agreement
are true and correct and that the Company and the Guarantors have complied with all agreements and
satisfied all conditions on their part to be performed or satisfied hereunder at or prior to the
Closing Date and (iii) to the effect set forth in paragraphs (a), (c) and (d) above.
(f) Comfort Letters. On the date of this Agreement and on the Closing Date, Xxxxx Xxxxxxxx
LLP shall have furnished to the Representative, at the request of the Company, letters, dated the
respective dates of delivery thereof and addressed to the Underwriters, in form and substance
reasonably satisfactory to the Representative, containing statements and information of the type
customarily included in accountants’ “comfort letters” to underwriters with respect to the
financial statements and certain financial information contained and incorporated by reference in
the Registration Statement, the Time of Sale Information and the Prospectus; provided that
the letter delivered on the Closing Date shall use a “cut-off” date no more than three business
days prior to the Closing Date. On the date of this Agreement and on the Closing Date, Xxxxx,
Xxxxxx & Co., P.C. shall have furnished to the Representative, at the request of the Company,
letters, dated the respective dates of delivery thereof and addressed to the Underwriters, in form
and substance reasonably satisfactory to the Representative, containing statements and information
of the type customarily included in accountants’ “comfort letters” to underwriters with respect to
the financial statements and certain financial information of the Xxxxx Group Properties
incorporated by reference in the Registration Statement, the Time of Sale Information and the
Prospectus; provided that the letter delivered on the Closing Date shall use a “cut-off”
date no more than three business days prior to the Closing Date.
(g) Reserve Letters. On the date of this Agreement and on the Closing Date, as the case may
be, each of Netherland, Xxxxxx & Associates, Inc. and Xxxxxx, Xxxxxxxxx & Associates, Inc. shall
have furnished to the Representatives, at the request of the Company, reserve report confirmation
letters, dated the respective dates of delivery thereof and addressed to the Underwriters, in form
and substance reasonably satisfactory to the Representative, containing statements and information
of the type customarily included in such letters to underwriters with respect to the reserve and
other operational information contained in the Registration Statement, the Time of Sale Information
and the Prospectus.
(h) Opinion of Counsel for the Company. Each of (i) Xxxxxx & Xxxxxx L.L.P., counsel for the
Company, and (ii) Xxxxx X. Xxxxxxxx, General Counsel of the Company, shall have furnished to the
Representative, at the request of the Company, their respective written opinions, dated the Closing
Date and addressed to the Underwriters, in form and substance reasonably satisfactory to the
Representative, to the effect set forth in Annex A-1 and A-2 hereto, respectively.
(i) Opinion and 10b-5 Statement of Counsel for the Underwriters. The Representative shall
have received on and as of the Closing Date an opinion and 10b-5 statement of Xxxxxxx Xxxxxxx &
Xxxxxxxx LLP, counsel for the Underwriters, with respect to such matters
19
as the Representative may reasonably request, and such counsel shall have received such
documents and information as they may reasonably request to enable them to pass upon such matters.
(j) No Legal Impediment to Issuance. No action shall have been taken and no statute, rule,
regulation or order shall have been enacted, adopted or issued by any federal, state or foreign
governmental or regulatory authority that would, as of the Closing Date, prevent the issuance or
sale of the Securities or the issuance of the Guarantees; and no injunction or order of any
federal, state or foreign court shall have been issued that would, as of the Closing Date, prevent
the issuance or sale of the Securities or the issuance of the Guarantees.
(k) Good Standing. The Representative shall have received on and as of the Closing Date
satisfactory evidence of the good standing of the Company and the Guarantors in their respective
jurisdictions of organization and their good standing in such other jurisdictions as the
Representative may reasonably request, in each case in writing or any standard form of
telecommunication from the appropriate governmental authorities of such jurisdictions.
(l) Additional Documents. On or prior to the Closing Date, the Company and the Guarantors
shall have furnished to the Representative such further certificates and documents as the
Representative may reasonably request.
All opinions, letters, certificates and evidence mentioned above or elsewhere in this
Agreement shall be deemed to be in compliance with the provisions hereof only if they are in form
and substance reasonably satisfactory to counsel for the Underwriters.
7. Indemnification and Contribution.
(a) Indemnification of the Underwriters. The Company and each of the Guarantors jointly and
severally agree to indemnify and hold harmless each Underwriter, its affiliates, directors and
officers and each person, if any, who controls such Underwriter within the meaning of Section 15 of
the Securities Act or Section 20 of the Exchange Act, from and against any and all losses, claims,
damages and liabilities (including, without limitation, reasonable legal fees and other expenses
incurred in connection with any suit, action or proceeding or any claim asserted, as such fees and
expenses are incurred), joint or several, that arise out of, or are based upon, (i) any untrue
statement or alleged untrue statement of a material fact contained in the Registration Statement or
caused by any omission or alleged omission to state therein a material fact required to be stated
therein or necessary in order to make the statements therein, not misleading, (ii) or any untrue
statement or alleged untrue statement of a material fact contained in the Prospectus (or any
amendment or supplement thereto), any Issuer Free Writing Prospectus or any Time of Sale
Information, or caused by any omission or alleged omission to state therein a material fact
necessary in order to make the statements therein, in light of the circumstances under which they
were made, not misleading, in each case except insofar as such losses, claims, damages or
liabilities arise out of, or are based upon, any untrue statement or omission or alleged untrue
statement or omission made in reliance upon and in conformity with any information relating to any
Underwriter furnished to the Company in writing by such Underwriter through the Representative
expressly for use therein, it being understood and agreed that the only such
20
information furnished by any Underwriter consists of the information described as such in
subsection (b) below.
The Company also agrees to indemnify and hold harmless Xxxxxxx Xxxxx & Associates, Inc., its
affiliates, directors and officers and each person, if any, who controls Xxxxxxx Xxxxx &
Associates, Inc. within the meaning of Section 15 of the Securities Act or Section 20 of the
Exchange Act, from and against any and all losses, claims, damages and liabilities incurred as a
result of Xxxxxxx Xxxxx & Associates, Inc.’s participation as a “qualified independent underwriter”
within the meaning of NASD Rule 2720 of FINRA in connection with the offering of the Securities.
(b) Indemnification of the Company and the Guarantors. Each Underwriter agrees, severally and
not jointly, to indemnify and hold harmless the Company, each of the Guarantors, each of their
respective directors, their respective officers who signed the Registration Statement and each
person, if any, who controls the Company or any of the Guarantors within the meaning of Section 15
of the Securities Act or Section 20 of the Exchange Act to the same extent as the indemnity set
forth in paragraph (a) above, but only with respect to any losses, claims, damages or liabilities
that arise out of, or are based upon, any untrue statement or omission or alleged untrue statement
or omission made in reliance upon and in conformity with any information relating to such
Underwriter furnished to the Company in writing by such Underwriter through the Representative
expressly for use in the Registration Statement, the Prospectus (or any amendment or supplement
thereto), any Issuer Free Writing Prospectus or any Time of Sale Information, it being understood
and agreed that the only such information consists of the following: the concession and
reallowance figures appearing in the third paragraph under the caption “Underwriting”, the
information contained in the third and fourth sentences of the fifth paragraph under the caption
“Underwriting” and the information contained in the ninth paragraph under the caption
“Underwriting.”
(c) Notice and Procedures. If any suit, action, proceeding (including any governmental or
regulatory investigation), claim or demand shall be brought or asserted against any person in
respect of which indemnification may be sought pursuant to either paragraph (a) or (b) above, such
person (the “Indemnified Person”) shall promptly notify the person against whom such
indemnification may be sought (the “Indemnifying Person”) in writing; provided that the
failure to notify the Indemnifying Person shall not relieve it from any liability that it may have
under this Section 7 except to the extent that it has been materially prejudiced (through the
forfeiture of substantive rights or defenses) by such failure; and provided,
further, that the failure to notify the Indemnifying Person shall not relieve it from any
liability that it may have to an Indemnified Person otherwise than under this Section 7. If any
such proceeding shall be brought or asserted against an Indemnified Person and it shall have
notified the Indemnifying Person thereof, the Indemnifying Person shall retain counsel reasonably
satisfactory to the Indemnified Person (who shall not, without the consent of the Indemnified
Person, be counsel to the Indemnifying Person) to represent the Indemnified Person in such
proceeding and shall pay the fees and expenses of such counsel related to such proceeding, as
incurred. In any such proceeding, any Indemnified Person shall have the right to retain its own
counsel, but the fees and expenses of such counsel shall be at the expense of such Indemnified
Person unless (i) the Indemnifying Person and the Indemnified Person shall have mutually agreed to
the contrary; (ii) the Indemnifying Person has failed within a reasonable time to retain counsel
reasonably
21
satisfactory to the Indemnified Person; (iii) the Indemnified Person shall have reasonably
concluded that there may be legal defenses available to it that are different from or in addition
to those available to the Indemnifying Person; or (iv) the named parties in any such proceeding
(including any impleaded parties) include both the Indemnifying Person and the Indemnified Person
and representation of both parties by the same counsel would be inappropriate due to actual or
potential differing interests between them. It is understood and agreed that the Indemnifying
Person shall not, in connection with any proceeding or related proceeding in the same jurisdiction,
be liable for the fees and expenses of more than one separate firm (in addition to any local
counsel) for all Indemnified Persons, and that all such fees and expenses shall be reimbursed as
they are incurred, provided, however that if indemnity may be sought pursuant to the second
paragraph of Section 7(a) above in respect of such proceeding, then in addition to such separate
firm of the Underwriters, their affiliates and such control persons of the Underwriters the
indemnifying party shall be liable for the fees and expenses of not more than one separate firm (in
addition to any local counsel) for Xxxxxxx Xxxxx & Associates, Inc. in its capacity as a “qualified
independent underwriter”, its affiliates, directors, officers and all persons, if any, who control
Xxxxxxx Xxxxx & Associates, Inc. within the meaning of either Section 15 of the Securities Act or
Section 20 of the Exchange Act. Any such separate firm for any Underwriter, its affiliates,
directors and officers and any control persons of such Underwriter shall be designated in writing
by X.X. Xxxxxx Securities Inc. and any such separate firm for the Company, the Guarantors, their
respective directors, their respective officers who signed the Registration Statement and any
control persons of the Company shall be designated in writing by the Company. The Indemnifying
Person shall not be liable for any settlement of any proceeding effected without its written
consent, but if settled with such consent or if there be a final judgment for the plaintiff, the
Indemnifying Person agrees to indemnify each Indemnified Person from and against any loss or
liability by reason of such settlement or judgment. No Indemnifying Person shall, without the
written consent of the Indemnified Person, effect any settlement of any pending or threatened
proceeding in respect of which any Indemnified Person is or could have been a party and
indemnification could have been sought hereunder by such Indemnified Person, unless such settlement
(x) includes an unconditional release of such Indemnified Person, in form and substance reasonably
satisfactory to such Indemnified Person, from all liability on claims that are the subject matter
of such proceeding and (y) does not include any statement as to or any admission of fault,
culpability or a failure to act by or on behalf of any Indemnified Person.
(d) Contribution. If the indemnification provided for in paragraphs (a) and (b) above is
unavailable to an Indemnified Person or insufficient in respect of any losses, claims, damages or
liabilities referred to therein, then each Indemnifying Person under such paragraph, in lieu of
indemnifying such Indemnified Person thereunder, shall contribute to the amount paid or payable by
such Indemnified Person as a result of such losses, claims, damages or liabilities (i) in such
proportion as is appropriate to reflect the relative benefits received by the Company and the
Guarantors on the one hand and the Underwriters or Xxxxxxx Xxxxx & Associates, Inc. in its capacity
as a “qualified independent underwriter”, as the case may be, on the other from the offering of the
Securities or (ii) if the allocation provided by clause (i) is not permitted by applicable law, in
such proportion as is appropriate to reflect not only the relative benefits referred to in clause
(i) but also the relative fault of the Company and the Guarantors on the one hand and the
Underwriters or Xxxxxxx Xxxxx & Associates, Inc. in its capacity as a “qualified independent
underwriter”, as the case may be, on the other in connection with the statements or
22
omissions that resulted in such losses, claims, damages or liabilities, as well as any other
relevant equitable considerations. The relative benefits received by the Company on the one hand
and the Underwriters on the other shall be deemed to be in the same respective proportions as the
net proceeds (before deducting expenses) received by the Company from the sale of the Securities
and the total underwriting discounts and commissions received by the Underwriters in connection
therewith, in each case as set forth in the table on the cover of the Prospectus, bear to the
aggregate offering price of the Securities. The relative fault of the Company and the Guarantors
on the one hand and the Underwriters or Xxxxxxx Xxxxx & Associates, Inc. in its capacity as a
“qualified independent underwriter”, as the case may be, on the other shall be determined by
reference to, among other things, whether the untrue or alleged untrue statement of a material fact
or the omission or alleged omission to state a material fact relates to information supplied by the
Company or any Guarantor or by the Underwriters or Xxxxxxx Xxxxx & Associates, Inc. in its capacity
as a “qualified independent underwriter”, as the case may be, and the parties’ relative intent,
knowledge, access to information and opportunity to correct or prevent such statement or omission.
(e) Limitation on Liability. The Company, the Guarantors and the Underwriters agree that it
would not be just and equitable if contribution pursuant to this Section 7 were determined by
pro rata allocation (even if the Underwriters were treated as one entity for such
purpose) or by any other method of allocation that does not take account of the equitable
considerations referred to in paragraph (d) above. The amount paid or payable by an Indemnified
Person as a result of the losses, claims, damages and liabilities referred to in paragraph (d)
above shall be deemed to include, subject to the limitations set forth above, any legal or other
expenses incurred by such Indemnified Person in connection with any such action or claim.
Notwithstanding the provisions of this Section 7, in no event shall an Underwriter be required to
contribute any amount in excess of the amount by which the total underwriting discounts and
commissions received by such Underwriter with respect to the offering of the Securities exceeds the
amount of any damages that such Underwriter has otherwise been required to pay by reason of such
untrue or alleged untrue statement or omission or alleged omission. No person guilty of
fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be
entitled to contribution from any person who was not guilty of such fraudulent misrepresentation.
The Underwriters’ obligations to contribute pursuant to this Section 7 are several in proportion to
their respective purchase obligations hereunder and not joint.
(f) Non-Exclusive Remedies. The remedies provided for in this Section 7 are not exclusive and
shall not limit any rights or remedies which may otherwise be available to any Indemnified Person
at law or in equity.
8. Effectiveness of Agreement. This Agreement shall become effective upon the
execution and delivery hereof by the parties hereto.
9. Termination. This Agreement may be terminated in the absolute discretion of the
Representative, by notice to the Company, if after the execution and delivery of this Agreement and
prior to the Closing Date (i) trading generally shall have been suspended or materially limited on
the New York Stock Exchange or the over-the-counter market; (ii) trading of any securities issued
or guaranteed by the Company shall have been suspended on any exchange; (iii)
23
a general moratorium on commercial banking activities shall have been declared by federal or
New York State authorities; or (iv) there shall have occurred any outbreak or escalation of
hostilities or any change in financial markets or any calamity or crisis, either within or outside
the United States, that, in the judgment of the Representative, is material and adverse and makes
it impracticable or inadvisable to proceed with the offering, sale or delivery of the Securities on
the terms and in the manner contemplated by this Agreement, the Time of Sale Information and the
Prospectus.
10. Defaulting Underwriter. (a) If, on the Closing Date, any Underwriter defaults on
its obligation to purchase the Securities that it has agreed to purchase hereunder, the
non-defaulting Underwriters may in their discretion arrange for the purchase of such Securities by
other persons satisfactory to the Company on the terms contained in this Agreement. If, within 36
hours after any such default by any Underwriter, the non-defaulting Underwriters do not arrange for
the purchase of such Securities, then the Company shall be entitled to a further period of 36 hours
within which to procure other persons satisfactory to the non-defaulting Underwriters to purchase
such Securities on such terms. If other persons become obligated or agree to purchase the
Securities of a defaulting Underwriter, either the non defaulting Underwriters or the Company may
postpone the Closing Date for up to five full business days in order to effect any changes that in
the opinion of counsel for the Company or counsel for the Underwriters may be necessary in the
Registration Statement and the Prospectus or in any other document or arrangement, and the Company
agrees to promptly prepare any amendment or supplement to the Registration Statement and the
Prospectus that effects any such changes. As used in this Agreement, the term “Underwriter”
includes, for all purposes of this Agreement unless the context otherwise requires, any person not
listed in Schedule 1 hereto that, pursuant to this Section 10, purchases Securities that a
defaulting Underwriter agreed but failed to purchase.
(b) If, after giving effect to any arrangements for the purchase of the Securities of a
defaulting Underwriter or Underwriters by the non-defaulting Underwriters and the Company as
provided in paragraph (a) above, the aggregate principal amount of such Securities that remains
unpurchased does not exceed one-eleventh of the aggregate principal amount of all the Securities,
then the Company shall have the right to require each non-defaulting Underwriter to purchase the
principal amount of Securities that such Underwriter agreed to purchase hereunder plus such
Underwriter’s pro rata share (based on the principal amount of Securities that such
Underwriter agreed to purchase hereunder) of the Securities of such defaulting Underwriter or
Underwriters for which such arrangements have not been made.
(c) If, after giving effect to any arrangements for the purchase of the Securities of a
defaulting Underwriter or Underwriters by the non-defaulting Underwriters and the Company as
provided in paragraph (a) above, the aggregate principal amount of such Securities that remains
unpurchased exceeds one-eleventh of the aggregate principal amount of all the Securities, or if the
Company shall not exercise the right described in paragraph (b) above, then this Agreement shall
terminate without liability on the part of the non-defaulting Underwriters. Any termination of
this Agreement pursuant to this Section 10 shall be without liability on the part of the Company,
except that the Company will continue to be liable for the payment of expenses as set forth in
Section 11 hereof and except that the provisions of Section 7 hereof shall not terminate and shall
remain in effect.
24
(d) Nothing contained herein shall relieve a defaulting Underwriter of any liability it may
have to the Company or any non-defaulting Underwriter for damages caused by its default.
11. Payment of Expenses. (a) Whether or not the transactions contemplated by this
Agreement are consummated or this Agreement is terminated, the Company and each of the Guarantors
jointly and severally agree to pay or cause to be paid all costs and expenses incident to the
performance of their respective obligations hereunder, including without limitation, (i) the costs
incident to the sale, preparation and delivery of the Securities and any taxes payable in that
connection; (ii) the costs incident to the preparation, printing and filing under the Securities
Act of the Registration Statement, the Preliminary Prospectus, any Issuer Free Writing Prospectus,
any Time of Sale Information and the Prospectus (including all exhibits, amendments and supplements
thereto) and the distribution thereof; (iii) the costs of reproducing and distributing each of the
Transaction Documents; (iv) the fees and expenses of the Company’s and the Guarantors’ counsel and
independent accountants; (v) the fees and expenses incurred in connection with the registration or
qualification and determination of eligibility for investment of the Securities under the laws of
such jurisdictions as the Representative may designate and the preparation, printing and
distribution of a Blue Sky Memorandum (including the related reasonable fees and expenses of
counsel for the Underwriters); (vi) any fees charged by rating agencies for rating the Securities;
(vii) the fees and expenses of the Trustee and any paying agent (including related fees and
expenses of any counsel to such parties); (viii) all application fees incurred in connection with
any filing with, and clearance of the offering by, FINRA; and (ix) all expenses incurred by the
Company in connection with any “road show” presentation to potential investors; provided that
notwithstanding clause (ix) above, the Underwriters shall pay one-half of the lease expenses
associated with any airplane which is used for the purposes of such “road show” presentations.
(b) If (i) the Company for any reason fails to tender the Securities for delivery to the
Underwriters or (ii) the Underwriters decline to purchase the Securities for any reason permitted
under this Agreement (other than Section 9, but excluding any termination of this Agreement by the
Representative pursuant to clause (ii) thereof), the Company agrees to reimburse the Underwriters
for all out-of-pocket costs and expenses (including the reasonable fees and expenses of their
counsel) reasonably incurred by the Underwriters in connection with this Agreement and the offering
contemplated hereby.
12. Persons Entitled to Benefit of Agreement. This Agreement shall inure to the
benefit of and be binding upon the parties hereto and their respective successors and the officers
and directors and any controlling persons referred to herein, and the affiliates of each
Underwriter referred to in Section 7 hereof. Nothing in this Agreement is intended or shall be
construed to give any other person any legal or equitable right, remedy or claim under or in
respect of this Agreement or any provision contained herein. No purchaser of Securities from any
Underwriter shall be deemed to be a successor merely by reason of such purchase.
13. Survival. The respective indemnities, rights of contribution, representations,
warranties and agreements of the Company, the Guarantors and the Underwriters contained in this
Agreement or made by or on behalf of the Company, the Guarantors or the Underwriters pursuant to
this Agreement or any certificate delivered pursuant hereto shall survive the delivery of and
payment for the Securities and shall remain in full force and effect, regardless of any
25
termination of this Agreement or any investigation made by or on behalf of the Company or the
Underwriters.
14. Certain Defined Terms. For purposes of this Agreement, (a) except where otherwise
expressly provided, the term “affiliate” has the meaning set forth in Rule 405 under the Securities
Act; (b) the term “business day” means any day other than a day on which banks are permitted or
required to be closed in New York City; and (c) the term “subsidiary” has the meaning set forth in
Rule 405 under the Securities Act.
15. Miscellaneous. (a) Authority of the Representative. Any action by the
Underwriters hereunder may be taken by X.X. Xxxxxx Securities Inc. on behalf of the Underwriters,
and any such action taken by X.X. Xxxxxx Securities Inc. shall be binding upon the Underwriters.
(b) Notices. All notices and other communications hereunder shall be in writing and shall be
deemed to have been duly given if mailed or transmitted and confirmed by any standard form of
telecommunication. Notices to the Underwriters shall be given to the Representative c/o X.X.
Xxxxxx Securities Inc., 000 Xxxx Xxxxxx, Xxx Xxxx, Xxx Xxxx 00000 (fax: 000-000-0000); Attention:
Xxx Xxxxxxxxxxx. Notices to the Company shall be given to it at Concho Resources Inc., 000 X.
Xxxxx Xxxxxx, Xxxxx 000, Xxxxxxx, Xxxxx 00000, (fax: (000) 000-0000), Attention: Xxxxx X. Xxxxxxxx,
Vice President and General Counsel, with a copy to T. Xxxx Xxxxx, Xxxxxx & Xxxxxx L.L.P., 0000
Xxxxxx Xxxxxx, Xxxxx 0000, Xxxxxxx, Xxxxx 00000 (fax: (000) 000-0000).
(c) Governing Law. This Agreement shall be governed by and construed in accordance with the
laws of the State of New York.
(d) Counterparts. This Agreement may be signed in counterparts (which may include
counterparts delivered by any standard form of telecommunication), each of which shall be an
original and all of which together shall constitute one and the same instrument.
(e) Amendments or Waivers. No amendment or waiver of any provision of this Agreement, nor any
consent or approval to any departure therefrom, shall in any event be effective unless the same
shall be in writing and signed by the parties hereto.
(f) Headings. The headings herein are included for convenience of reference only and are not
intended to be part of, or to affect the meaning or interpretation of, this Agreement.
26
If the foregoing is in accordance with your understanding, please indicate your acceptance of
this Agreement by signing in the space provided below.
Very truly yours, CONCHO RESOURCES INC. |
||||
By | /s/ Xxxxx X. Xxxxxxxx | |||
Name: | Xxxxx X. Xxxxxxxx | |||
Title: | Vice President, General Counsel and Secretary | |||
COG OPERATING LLC COG REALTY LLC CONCHO ENERGY SERVICES LLC QUAIL RANCH LLC |
||||
By | /s/ Xxxxx X. Xxxxxxxx | |||
Name: | Xxxxx X. Xxxxxxxx | |||
Title: | Vice President, General Counsel and Secretary | |||
Accepted: September 15, 2009
X.X. XXXXXX SECURITIES INC.
For itself and on behalf of the
several Underwriters listed
in Schedule 1 hereto.
several Underwriters listed
in Schedule 1 hereto.
By
|
/s/ Xxxx X. Xxxxx | |||
Title: Executive Director |
27
Schedule 1
Underwriter | Principal Amount | |||
X.X. Xxxxxx Securities Inc. |
$ | 120,000,000 | ||
Xxxxx Fargo Securities, LLC |
30,000,000 | |||
Banc of America Securities LLC |
45,000,000 | |||
BNP Paribas Securities Corp. |
30,000,000 | |||
Calyon Securities (USA) Inc. |
15,000,000 | |||
Scotia Capital (USA) Inc. |
15,000,000 | |||
SunTrust Xxxxxxxx Xxxxxxxx, Inc. |
15,000,000 | |||
Deutsche Bank Securities Inc. |
5,001,000 | |||
ING Financial Markets LLC |
5,001,000 | |||
KeyBanc Capital Markets Inc. |
5,001,000 | |||
Mitsubishi UFJ Securities (USA), Inc. |
5,001,000 | |||
Natixis Bleichroeder Inc. |
5,001,000 | |||
Xxxxxxx Xxxxx & Associates, Inc. |
4,995,000 | |||
Total |
$ | 300,000,000 |
S-1-1
Schedule 2
Guarantors
COG Operating LLC
COG Realty LLC
Concho Energy Services LLC
Quail Ranch LLC
COG Realty LLC
Concho Energy Services LLC
Quail Ranch LLC
S-2-1
Annex A
Form of Opinion of Xxxxxx & Xxxxxx L.L.P.
(1) The Registration Statement is an “automatic shelf registration statement” as defined under
Rule 405 of the Securities Act that has been filed with the Commission not earlier than three years
prior to the date of the Underwriting Agreement; each of the Preliminary Prospectus and the
Prospectus was filed with the Commission pursuant to the subparagraph of Rule 424(b) under the
Securities Act specified in such opinion on the date specified therein; and, to such counsel’s
knowledge, no order suspending the effectiveness of the Registration Statement has been issued, no
notice of objection of the Commission to the use of such registration statement or any
post-effective amendment thereto pursuant to Rule 401(g)(2) under the Securities Act has been
received by the Company and, to the knowledge of such counsel, no proceeding for that purpose or
pursuant to Section 8A of the Securities Act against the Company or in connection with the offering
is pending or threatened by the Commission.
(2) The Registration Statement, the Preliminary Prospectus, each Issuer Free Writing
Prospectus included in the Time of Sale Information and the Prospectus (other than the financial
statements and related schedules therein, as to which such counsel need express no opinion) comply
as to form in all material respects with the requirements of the Securities Act.
(3) The Company is in good standing as a corporation under the laws of the State of Delaware,
with corporate power and authority to execute and deliver each of the Transaction Documents to
which it is a party and to perform its obligations thereunder; the Delaware Guarantor is validly
existing and in good standing as a limited liability company under the laws of the State of
Delaware, with limited liability company power and authority to execute and deliver each of the
Transaction Documents to which it is a party and to perform its obligations thereunder; each of the
Texas Guarantors is validly existing and in good standing as a limited liability company under the
laws of the State of Texas, with limited liability company power and authority to execute and
deliver each of the Transaction Documents to which each is a party and to perform their respective
obligations thereunder.
(4) Each of the Base Indenture and the First Supplemental Indenture has been duly authorized,
executed and delivered by the Company and each of the Guarantors and the Indenture has been duly
qualified under the Trust Indenture Act and, assuming due execution and delivery thereof by the
Trustee, the Indenture constitutes a valid and legally binding agreement of the Company and each of
the Guarantors enforceable against the Company and each of the Guarantors in accordance with its
terms, subject to the Enforceability Exceptions.
(5) The Securities have been duly authorized, executed and delivered by the Company and, when
duly authenticated as provided in the Indenture and paid for as provided in this Agreement, will be
duly and validly issued and outstanding and will constitute valid and legally binding obligations
of the Company enforceable against the Company in accordance with their terms, subject to the
Enforceability Exceptions; and the Guarantees have been duly authorized by each of the Guarantors
and, when the Securities have been duly executed, authenticated, issued and delivered as provided
in the Indenture and paid for as provided in this Agreement, will be valid and legally binding
obligations of each of the Guarantors, enforceable
A-1-1
against each of the Guarantors in accordance with their terms, subject to the Enforceability
Exceptions.
(6) This Agreement has been duly authorized, executed and delivered by the Company and the
Guarantors.
(7) The description of each Transaction Document contained in the Registration Statement, the
Time of Sale Information and the Prospectus is accurate in all material respects.
(8) The execution, delivery and performance by the Company and each of the Guarantors of each
of the Transaction Documents to which each is a party, the issuance and sale of the Securities
(including the Guarantees) and compliance by the Company and each of the Guarantors with the terms
thereof and the consummation of the transactions contemplated by the Transaction Documents will not
(i) conflict with or result in a breach or violation of any of the terms or provisions of, or
constitute a default under, or result in the creation or imposition of any lien, charge or
encumbrance upon any property or assets of the Company or any of its subsidiaries pursuant to, any
document filed as an Exhibit to the Registration Statement, (ii) result in any violation of the
provisions of the charter or by-laws or similar organizational documents of the Company or any of
its subsidiaries or (iii) result in the violation of any law or statute or any judgment, order or
regulation of any court or arbitrator or governmental or regulatory authority known to such
counsel, except, in the case of clauses (i) and (iii) above, for any such conflict, breach,
violation, default, lien, charge or encumbrance that would not, individually or in the aggregate,
have a Material Adverse Effect. With respect to clause (iii) above, we express no opinion as to
the application of any state securities or Blue Sky laws or federal or state antifraud laws, rules
or regulations.
(9) No consent, approval, authorization, order, registration or qualification of or with any
court or arbitrator or governmental or regulatory authority is required for the execution, delivery
and performance by the Company and each of the Guarantors of each of the Transaction Documents to
which each is a party, the issuance and sale of the Securities (including the Guarantees) and
compliance by the Company and each of the Guarantors with the terms thereof and the consummation of
the transactions contemplated by the Transaction Documents, except for the registration of the
Securities under the Securities Act, the qualification of the Indenture under the Trust Indenture
Act and such consents, approvals, authorizations, orders and registrations or qualifications as may
be required under applicable state securities laws in connection with the purchase and distribution
of the Securities by the Underwriters and any consent, approval, authorization, order, registration
or qualification that either has been, or prior to the Closing Date will have been, obtained or
made, or which if not obtained or made, would not, individually or in the aggregate, have a
Material Adverse Effect.
(10) The descriptions in the Registration Statement, the Time of Sale Information and the
Prospectus under the heading “United States federal income and estate tax consequences” to the
extent that they constitute summaries of matters of law or regulation or legal conclusions, are
accurate in all material respects.
(11) Neither the Company nor any of its subsidiaries is, and, after giving effect to the
offering and sale of the Securities and the application of the proceeds thereof as described in the
A-1-2
Registration Statement, the Time of Sale Information and the Prospectus, none of them will be
an “investment company” within the meaning of the Investment Company Act.
(12) The documents incorporated by reference in the Time of Sale Information and the
Prospectus or any further amendment or supplement thereto made by the Company prior to the Closing
Date (other than the financial statements and related schedules therein, as to which such counsel
need express no opinion), when they were filed with the Commission, complied as to form in all
material respects with the requirements of the Exchange Act and the rules and regulations of the
Commission thereunder.
Such counsel shall also state that they have participated in conferences with representatives
of the Company and with representatives of its independent accountants and counsel at which
conferences the contents of the Registration Statement, the Time of Sale Information and the
Prospectus and any amendment and supplement thereto and related matters were discussed and,
although such counsel assume no responsibility for, or express any opinion regarding (other than as
listed in opinion (10) above), the accuracy, completeness or fairness of the Registration
Statement, the Time of Sale Information, the Prospectus and any amendment or supplement thereto
(except as expressly provided above), based upon the participation described above (relying as to
factual matters in respect to the determination by such counsel of materiality to the extent such
counsel deems reasonable upon statements of fact made to such counsel by representatives of the
Company) and subject to the next succeeding sentence, nothing has come to the attention of such
counsel to cause such counsel to believe that the Registration Statement, at the time of its
effective date (including the information, if any, deemed pursuant to Rule 430A, 430B or 430C to be
part of the Registration Statement at the time of effectiveness), contained any untrue statement of
a material fact or omitted to state a material fact required to be stated therein or necessary to
make the statements therein not misleading, that the Time of Sale Information, at the Time of Sale
(which such counsel may assume to be the date of the Underwriting Agreement) contained any untrue
statement of a material fact or omitted to state a material fact necessary to make the statements
therein, in the light of the circumstances under which they were made, not misleading or that the
Prospectus or any amendment or supplement thereto as of its date and the Closing Date contained or
contains any untrue statement of a material fact or omitted or omits to state a material fact
necessary to make the statements therein, in the light of the circumstances under which they were
made, not misleading. In making the foregoing statement, such counsel will not express any comment
or belief with respect to the financial statements and notes and related schedules (and other
financial and accounting data derived therefrom), the Form T-1 and the oil and natural gas reserve
estimates included in or omitted from the Registration Statement, the Time of Sale Information or
the Prospectus.
In rendering such opinion, such counsel may rely as to matters of fact on certificates of
responsible officers of the Company, the Guarantors and public officials that are furnished to the
Underwriters.
The opinion of Xxxxxx & Xxxxxx L.L.P. described above shall be rendered to the Underwriters at the
request of the Company and shall so state therein.
X-0-0
Xxxxx X-0
Form of Opinion of Xxxxx X. Xxxxxxxx
(1) The Company and each of its subsidiaries have been duly organized and are validly existing
and in good standing under the laws of their respective jurisdictions of organization, are duly
qualified to do business and are in good standing in each jurisdiction in which their respective
ownership or lease of property or the conduct of their respective businesses requires such
qualification, and have all power and authority necessary to own or hold their respective
properties and to conduct the businesses in which they are engaged, except where the failure to be
in good standing or so qualified or have such power or authority would not, individually or in the
aggregate, have a Material Adverse Effect.
(2) The Company has an authorized equity capitalization as set forth in the Registration
Statement, the Time of Sale Information and the Prospectus under the heading “Capitalization” and
all the outstanding shares of capital stock or other equity interests of each subsidiary of the
Company have been duly and validly authorized and issued, are fully paid and non-assessable.
(3) To the knowledge of such counsel, except as described in the Registration Statement, the
Time of Sale Information and the Prospectus, there are no legal, governmental or regulatory
investigations, actions, suits or proceedings pending to which the Company or any of its
subsidiaries is or is reasonably expected to be a party or to which any property of the Company or
any of its subsidiaries is or is reasonably expected to be the subject which, individually or in
the aggregate, if determined adversely to the Company or any of its subsidiaries, could reasonably
be expected to have a Material Adverse Effect; and, to the knowledge of such counsel, no such
investigations, actions, suits or proceedings are threatened or contemplated by any governmental or
regulatory authority or threatened by others.
A-2-1
Annex B
Time of Sale Information
Term sheet in the form of Annex C hereto.
B-1
Annex C
Issuer Free Writing Prospectus
Filed by: Concho Resources Inc.
Pursuant to Rule 433 under the Securities Act of 1933
Registration Statement on Form S-3: No. 333-161809
Filed by: Concho Resources Inc.
Pursuant to Rule 433 under the Securities Act of 1933
Registration Statement on Form S-3: No. 333-161809
Concho Resources Inc.
Pricing Term Sheet
Pricing Term Sheet
This Pricing Term Sheet is qualified in its entirety by reference to the Preliminary Prospectus
Supplement, dated September 9, 2009. The information in this Pricing Term Sheet supplements the
Preliminary Prospectus Supplement and supersedes the information in the Preliminary Prospectus
Supplement to the extent it is inconsistent with the information in the Preliminary Prospectus
Supplement. Capitalized terms used in this Pricing Term Sheet but not defined have the meanings
given them in the Preliminary Prospectus Supplement.
Issuer: |
Concho Resources Inc. | |
Size: |
$300,000,000 | |
Maturity: |
October 1, 2017 | |
Coupon: |
8.625% | |
Price: |
98.578% of face amount | |
Yield to maturity: |
8.875% | |
Spread to Benchmark Treasury: |
+ 566 basis points | |
Benchmark Treasury: |
UST 4.75% due 8/15/2017 | |
Interest Payment Dates: |
April 1 and October 1, commencing April 1, 2010 | |
Gross Proceeds: |
$295,734,000 | |
Net Proceeds to the Issuer (before expenses): |
$288,234,000 | |
Redemption Provisions: |
||
First call date: |
October 1, 2013 | |
Make-whole call: |
Before the first call date at a discount rate | |
of Treasury plus 50 basis points | ||
Redemption prices: |
||
Commencing October 1, 2013: 104.313% | ||
Commencing October 1, 2014: 102.156% | ||
Commencing October 1, 2015: 100.000% | ||
Redemption with proceeds of equity offering |
Prior to 2012, up to 35% may be redeemed at 108.625% | |
Change of control: |
Put at 101% of principal plus accrued interest | |
Trade date: |
September 15, 2009 | |
Settlement: |
T+3; September 18, 2009 | |
Denominations: |
$2,000 and integral multiples of $1,000 | |
CUSIP/ISIN: |
00000XXX0/US20605PAA93 | |
Form of Offering: |
SEC Registered (Registration No. 333-161809) | |
Ratings: |
Xxxxx’x: B31 | |
S&P: BB1 | ||
Joint book-running managers: |
X.X. Xxxxxx Securities Inc. | |
Banc of America Securities LLC | ||
BNP Paribas Securities Corp. | ||
Xxxxx Fargo Securities, LLC | ||
Co-managers: |
Calyon Securities (USA) Inc. | |
Scotia Capital (USA) Inc. | ||
SunTrust Xxxxxxxx Xxxxxxxx, Inc. | ||
Deutsche Bank Securities Inc. | ||
ING Financial Markets LLC | ||
KeyBanc Capital Markets Inc. | ||
Mitsubishi UFJ Securities (USA), Inc. |
C-1
Natixis Bleichroeder Inc. | ||
Xxxxxxx Xxxxx & Associates, Inc. |
1 | A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time. |
The issuer has filed a registration statement (including a prospectus and prospectus supplement)
with the SEC for the offering to which this communication relates. Before you invest, you should
read the prospectus in that registration statement and other documents the issuer has filed with
the SEC for more complete information about the issuer and this offering. You may get these
documents for free by visiting XXXXX on the SEC Web site at xxx.xxx.xxx. Alternatively, the
issuer, any underwriter or any dealer participating in the offering will arrange to send you the
prospectus if you request it by contacting X.X. Xxxxxx Securities Inc. at 000 Xxxx Xxxxxx, 0xx
Xxxxx, Xxx Xxxx, XX 00000, Attention: Syndicate Desk or by calling (000) 000-0000; Banc of America
Securities LLC at Xxx Xxxxxx Xxxx, Xxx Xxxx, XX 00000, Attention: Prospectus Department or by
calling (000) 000-0000; BNP Paribas Securities Corp., 000 Xxxxxxx Xxxxxx, Xxx Xxxx, XX 00000,
Attention: Syndicate Desk 7th Floor, or by calling (000) 000-0000; or Xxxxx Fargo Securities, LLC
at 000 Xxxxx Xxxxxxx Xxxxxx, 0xx Xxxxx, Xxxxxxxxx, XX 00000, Attention: High Yield Syndicate or by
calling (000) 000-0000.
Additional Information
Ranking
The following disclosure under “Summary—The offering—Ranking” on page S-7 and each other location
where it appears in the preliminary prospectus supplement is amended to read as follows:
As of June 30, 2009, after giving effect to the issuance and sale of the notes and the application
of the estimated net proceeds therefrom as set forth under “Use of proceeds” to repay a portion of
the borrowings outstanding under our credit facility, we would have had total consolidated
indebtedness, net of discount of $668.8 million, consisting of $373.0 million of secured
indebtedness outstanding under our credit facility and $295.8 million of the notes net of discount
offered hereby, the subsidiary guarantors would have had total indebtedness of $668.8 million,
consisting of $373.0 million of secured guarantees under our credit facility and $295.8 million of
guarantees of the notes net of discount offered hereby, excluding intercompany indebtedness, and we
would have been able to incur an additional $582.8 million of secured indebtedness under our credit
facility.
Original Issue Discount
We expect that the notes will not be issued with original issue discount, or OID, for U.S. federal
income tax purposes.
Use of Proceeds
The following disclosure under “Use of proceeds” on page S-42 and each other location where it
appears in the preliminary prospectus supplement is amended to read as follows:
The net proceeds from this offering will be approximately $287.0 million, after deducting fees and
estimated expenses (including underwriting discounts and commissions). We intend to use the net
proceeds from this offering to repay a portion of the outstanding borrowings under our credit
facility.
Capitalization
The following numbers in the As adjusted column under “Capitalization” on page S-43 and each other
location where they appear in the preliminary prospectus supplement are amended to read as follows:
C-2
As of June 30, 2009 As | ||||
adjusted | ||||
(in millions) | ||||
Long-term debt: |
||||
Credit facility(a) |
373.0 | |||
8.625% Senior Notes due 2017(b) |
295.8 | |||
Total long-term debt |
668.8 | |||
Total capitalization |
$ | 1,958.3 |
(a) | As of June 30, 2009, after giving effect to the issuance and sale of the notes and the application of the estimated net proceeds therefrom and the automatic reduction in the borrowing base under our credit facility resulting from the issuance of the notes, we would have been able to incur an additional $582.8 million of indebtedness under our credit facility. | |
(b) | The $300.0 million of senior notes are recorded at their discounted amount, with the discount to be amortized over the life of the senior notes. |
Description of other indebtedness
The following disclosure under “Description of other indebtedness—Senior secured credit facility”
on page S-110 of the preliminary prospectus supplement is amended to read as follows:
Following the termination of our second lien credit facility on July 31, 2008, our only outstanding
long-term indebtedness exists under our credit facility. Our credit facility is subject to
scheduled semiannual borrowing base redeterminations, and has a maturity date of July 31, 2013. In
April 2009, the lenders reaffirmed our $960 million borrowing base under the credit facility until
the next scheduled borrowing base redetermination in October 2009. Between scheduled borrowing base
redeterminations, we and, if requested by 662/3 percent of the lenders, the lenders, may each request
one special redetermination. At June 30, 2009, we had letters of credit outstanding under our
credit facility totaling approximately $25,000, and our availability to borrow additional funds was
approximately $300 million. Pursuant to the terms of our credit facility, our borrowing base will
be reduced by $0.30 for every dollar of new indebtedness evidenced by unsecured senior notes or
unsecured senior subordinated notes that we issue. As a result of this provision, the borrowing
base under our credit facility would have been reduced by $75 million due to our issuance and sale
of the notes. However, as of the date hereof we have received waivers of this provision from
lenders representing approximately 95.4% of our borrowing base, resulting in an actual reduction of
approximately $4.1 million. As a result, following the application of the proceeds of this offering
in the manner described in “Use of proceeds” and giving effect to the reduction to our borrowing
base as a result of the issuance of the notes offered hereby, we expect to have approximately
$582.8 million of availability under our credit facility and a revised borrowing base of $955.9
million. To the extent we receive any additional waivers of this provision from the lenders after
the date hereof but before the closing of this offering, our borrowing base availability would
increase accordingly.
C-3